Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

New Tick-Borne Disease Found

By LabMedica International staff writers
Posted on 17 Sep 2012
A new Phlebovirus, dubbed the "Heartland virus," is being spread to people by ticks common in the Southeastern part of the USA.

The only tickborne Phlebovirus known to cause human disease is severe fever with thrombocytopenia syndrome virus (SFTSV), which was recently identified in central and northeastern China. More...


Scientists at US Centers of Disease Control and Prevention (CDC; Atlanta, GA, USA) collected leukocytes from two patients on day two of hospitalization. Both men had fever, fatigue, diarrhea, and low levels of blood platelets and white blood cells and had reportedly been bitten by ticks. The symptoms are similar to those of ehrlichiosis, a relatively common tick-borne disease that is caused by bacteria.

The leukocytes were inoculated onto cultures of macrophage-monocyte cell line from a dog with malignant histiocytosis (DH82). Total ribonucleic acid (RNA) was isolated from infected culture media and subjected to next-generation sequencing using quantitative reverse transcription PCR (qRT-PCR). The resulting full-length genome sequences were found to be similar to those of phleboviruses in the Bunyaviridae family, which are single-stranded, negative-sense RNA viruses comprised of three genome segments.

Immunohistochemical staining of the bone marrow of one patient revealed the virus nucleocapsid protein in large mononuclear cells that did not resemble mature granulocytes, erythroid cells, or megakaryocytes. Patient serum samples were tested for the presence of antibodies reactive to the novel virus. In October 2011, more than two years after the onset of infection, blood was collected from both patients and serum samples were tested on enzyme-linked immunosorbent assay (ELISA) to detect immunoglobulin G (IgG) reactive with virus antigen made from inactivated virus-infected cell lysate. Both serum samples were strongly positive, with titers of more than 6,400.

Laura K. McMullan, PhD, and her colleagues concluded that although these two patients had severe disease, the incidence of infection with the novel virus and range of disease severity is currently unknown. This virus could be a more common cause of human illness than is currently recognized. They warn health professionals to be on the lookout for people who fall ill after getting tick bites and who do not get better after antibiotic treatment. The study was published on August 30, 2102, in the New England Journal of Medicine (NEJM).

Related Links:
US Centers of Disease Control and Prevention



Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
ESR Analyzer
TEST1 2.0
Laboratory Software
ArtelWare
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.